MedTrace Logo

An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

NCT03964168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2020-03-11

No results posted yet for this study

Summary

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Conditions

Interventions

DRUG

Biologic Agent

Patients who discontinued a bioloic agent

Sponsors & Collaborators

  • Janssen Scientific Affairs, LLC

    collaborator INDUSTRY

  • Psoriasis Treatment Center of Central New Jersey

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2020-03-03
Completion
2020-03-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03964168 on ClinicalTrials.gov